This site uses cookies. By using this site you agree to receiving cookies. View Policy.

97%
Raised
£419,395
Investors
289
Target
£430,000
Equity
1.69%
Pre-money valuation
£24,965,139

REPLICATE is here to change single tooth replacement with a patented, patient-friendly product that does not require drilling or destroying healthy teeth. Focus is the £18 billion tooth replacement market in the USA. Clinically validated in Europe, U.S. FDA filings are complete, awaiting approval.

  • Unique, disruptive approach to single tooth replacement
  • Raised over £17M from founders, VCs and crowd investors
  • Clearance to sell in the EU
  • Founders are serial entrepreneurs, sold last dental company to 3M

Idea

REPLICATE Dental Technologies PLC (RDT), based in Dublin, Ireland has developed, tested and refined a minimally-invasive, patented medical device for replacing teeth, part of the growing trend toward personalized medicine.

The REPLICATE Immediate Tooth Replacement System disrupts the £38 billion dental market in the UK, USA, EU, South Korea and Japan, currently dominated by three-unit dental bridges (13.2 million units, 7% CAGR) and traditional dental implant screws (3.5 million units, 5% CAGR).

Over the past 5 years, the Company has worked on clinically validating its product at selected sites in Europe but has not widely launched the REPLICATE System as the primary market is the retail dental segment in the U.S., representing approximately 50% of dollars spent globally on dental procedures. RDT filed a 510(k) pre-market notification with the U.S. Food and Drug Administration (FDA) and is awaiting regulatory approval to sell in the U.S.

To date, the Company has raised £17 million from founders, management, business angels, and venture capital firms in the U.S. and Europe. £2.4 million was raised on the German crowd investing platform Companisto.

The Company currently has operations in Berlin, Germany and Dallas, Texas, and underwent a restructuring in 2018, forming RDT as a holding company to prepare for capital market entry on EuroNext.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

To see the rest of the REPLICATE Dental Technologies pitch, join now. It's free, quick and easy.

Due to financial regulations, you need to join our community to view the full investment opportunity.

Join

Already registered?
Log in

Risk warning

Investments of this nature carry risks to your capital, including illiquidity, lack of dividends and dilution. Balance risk with a diversified portfolio. Read more. Approved as a financial promotion by Crowdcube Capital Limited, which is authorised and regulated by the Financial Conduct Authority.

Investment opportunities are not offers to the public and investors must be eligible Crowdcube members. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions. Please seek independent advice as required as Crowdcube does not give investment or tax advice.